Reply

Affiliations

¹ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
² Center for Hemostasis and Thrombosis Research, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA.

Manal F Abdelmalek et al. Hepatology. 2023.

. 2023 May 1;77(5):E111-E112.

doi: 10.1097/HEP.0000000000000285. Epub 2023 Jan 3.

¹ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
² Center for Hemostasis and Thrombosis Research, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA.

No abstract available

References

1. Shearer AM, Wang Y, Fletcher EK, Rana R, Michael ES, Nguyen N, et al. PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference. Hepatology. 2022;76:1778–93.
1. Wang J, Chakrabarty S, Bui Q, Ruf W, Samad F. Hematopoietic tissue factor-protease-activated receptor 2 signaling promotes hepatic inflammation and contributes to pathways of gluconeogenesis and steatosis in obese mice. Am J Pathol. 2015;185:524–35.
1. Rana R, Shearer AM, Fletcher EK, Nguyen N, Guha S, Cox DH, et al. PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease. Mol Metab. 2019;29:99–113.